[VIEW] agent=Pharmacy Compliance & Infusion Services Manager | scenario_id=116 | rounds=20

--- Round 0 ---
[R0.1] Pharmacy Compliance & Infusion Services Manager (speak, public): To ensure the planned expansion of our outpatient oncology infusion services is both safe and sustainable, I’d like to gather insights on projected patient demand and any anticipated changes in staffing requirements. Additionally, understanding the financial implications and any potential reimbursement challenges will help us mitigate risks to throughput. Could we discuss these aspects further?
[R0.2] Oncology Nursing Director (Infusion Center) (speak, private to=Pharmacy Compliance & Infusion Services Manager,Health System Finance & Strategy Manager): Absolutely, I can provide insights on projected patient demand. We are currently seeing an average of 18 new referrals per week, and our peak-hour chair occupancy is at 92%. To accommodate this, the proposed extended-hours schedule would add 2 hours from Monday to Thursday, which will also impact staffing needs. We estimate needing an additional 1.6 RN FTE to support this expansion. It's crucial we ensure that our operational changes align with compliance requirements and financial planning. Can we discuss those aspects further?
[R0.3] Health System Finance & Strategy Manager (speak, public): Based on the current patient demand of 18 new referrals per week and the peak-hour chair occupancy at 92%, it seems like the proposed expansion to add 2 hours from Monday to Thursday is a necessary step. With the estimate of needing an additional 1.6 RN FTE to support this expansion, we should also consider the financial implications. To help assess the feasibility, I can share that our capital budget for FY26 for infusion expansion is set at $250,000, and our net revenue per infusion visit is $620. We need to ensure that these financials align with the operational changes and compliance requirements. Can we also discuss any potential reimbursement challenges you foresee?

--- Round 1 ---
[R1.1] Pharmacy Compliance & Infusion Services Manager (speak, public): Thank you both for the insights on patient demand and staffing needs. Given the projected patient flow and the need for additional RN FTEs, I want to ensure we are also prepared for any reimbursement headwinds that could affect our throughput. Could you share if there are any anticipated challenges in reimbursement that we should be aware of? This will help us align our operational and financial plans effectively.
[R1.2] Oncology Nursing Director (Infusion Center) (speak, private to=Pharmacy Compliance & Infusion Services Manager,Health System Finance & Strategy Manager): While I cannot provide specifics on reimbursement challenges at this time, it's essential to consider the overall landscape of reimbursement policies that could impact our expansion. We should focus on ensuring compliance and operational feasibility while preparing for any financial implications that may arise. Let's ensure our operational plans are robust enough to navigate potential reimbursement uncertainties. Can we also confirm that there are no hidden regulatory red flags that could affect our plans?
[R1.3] Health System Finance & Strategy Manager (speak, public): I appreciate the commitment to ensuring compliance and operational feasibility. While we cannot disclose specific reimbursement challenges, I believe it would be prudent to start developing a robust operational plan that can adapt to potential changes in the reimbursement landscape. This will help mitigate any risks related to throughput. Additionally, I would like to confirm that we have no hidden regulatory red flags affecting our expansion plans. Can we agree on a timeline to review our compliance checks?

--- Round 2 ---
[R2.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R2.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R2.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 3 ---
[R3.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R3.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R3.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 4 ---
[R4.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R4.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R4.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 5 ---
[R5.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R5.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R5.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 6 ---
[R6.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R6.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R6.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 7 ---
[R7.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R7.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R7.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 8 ---
[R8.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R8.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R8.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 9 ---
[R9.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R9.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R9.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 10 ---
[R10.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R10.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R10.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 11 ---
[R11.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R11.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R11.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 12 ---
[R12.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R12.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R12.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 13 ---
[R13.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R13.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R13.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 14 ---
[R14.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R14.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R14.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 15 ---
[R15.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R15.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R15.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 16 ---
[R16.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R16.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R16.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 17 ---
[R17.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R17.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R17.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 18 ---
[R18.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R18.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R18.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 19 ---
[R19.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R19.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R19.3] Health System Finance & Strategy Manager (leave, public): 

